Health Care/Hospital

Red Seal brings New Zealand's #1 best-selling herbal and mineral toothpaste to Pharmaca Integrative Pharmacies, USA

AUCKLAND, New Zealand, Dec. 14, 2021 /PRNewswire/ -- Wednesday 14 December, 2021 , Red Seal is proud to announce their herbal and mineral toothpastes are now conveniently available at all 28 distinguished Pharmaca stores nationwide.  www.redseal.global/usa Pharmaca...

2021-12-15 10:41 2457

Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use

* QuantaMatrix's direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days comparedto conventional methods * Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinica...

2021-12-15 07:39 2430

Info-Tech Research Group Reveals 2022 Tech Trends

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Info-Tech Research Group, one of the fastest-growing information technology and research advisory firms in the world, has revealed its annual tech trend insights for the coming year. Info-Tech offers research, diagnostics, and workshops to systematically impr...

2021-12-15 06:00 3291

Cochl joins ABB's innovation growth hub SynerLeap for audio-based anomaly detection and emergency monitoring

SAN JOSE, Calif., Dec. 14, 2021 /PRNewswire/ -- Cochl has become a member of Synerleap, ABB's innovation growth hub located in the heart of the ABB's Head Office in VästeråsSweden. Synerleap aims to create an ecosystem where ABB can utilize and enable technology companies to grow and expand on a ...

2021-12-15 01:00 2576

ASH 2021 | Ascentage Pharma Releases Long-Term Clinical Data of Olverembatinib (HQP1351) in Oral Presentation Demonstrating Efficacy and Safety

SUZHOU, China, and ROCKVILLE, Md., Dec. 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated data from three ...

2021-12-14 22:04 3244

ASH 2021 | Ascentage Pharma Presents Latest Data from Two Studies of Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a China Study Demonstrating Complete Responses

SUZHOU, China and ROCKVILLE, Md., Dec. 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released the updated data from six st...

2021-12-14 22:04 2906

Jolly Good launches R&D of VR therapy for chronic pain with Aichi Medical University's Pain Center.

TOKYO, Dec. 14, 2021 /PRNewswire/ -- Jolly Good Inc. ("Jolly Good"), in collaboration with Aichi Medical University Hospital's Pain Center ("Aichi Medical University"), the first interdisciplinary treatment and research facility for pain inJapan, will research the efficacy of VR therapy for chron...

2021-12-14 21:00 2239

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

MELBOURNE, Australia, Dec. 14, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that the New Zealand Medicines and Medic...

2021-12-14 20:25 2654

CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd

MELBOURNE, Australia and ST. GALLEN, Switzerland, Dec. 14, 2021 /PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14 December, 2021 - Expands CSL's leadership across an attractive portfolio ...

2021-12-14 14:59 3632

Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

CAMBRIDGE, Mass. and INCHEON, South Korea, Dec. 14, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Sp...

2021-12-14 13:34 2642

Orelabrutinib Data Presented at the 63rd Annual Meeting of ASH

BEIJING, Dec. 13, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that leading PIs presented latest data of BTK inhibitor orelabrutinib at the 63rd American Society of Hematology (ASH) Annual Meeting onDecember 11-14, 2021, which is hold online and o...

2021-12-14 12:50 2570

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

INCHEON, South Korea, Dec. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS), the world's leading contract development and manufacturing organization, continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN). The partnership is based on an...

2021-12-14 08:55 2783

KAZIA THERAPEUTICS APPOINTS KAREN KRUMEICH AS CHIEF FINANCIAL OFFICER

SYDNEY, Dec. 13, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the appointment ofKaren Krumeich as Chief Financial Officer. In this role, Ms Krumeich will focus on building and maintaining relatio...

2021-12-14 00:00 3772

Old Drugs Given New Life: Acura NanoMedicine Inc. Upgrades Existing Drugs Providing a More Efficient the Treatment for Cancer

TAIPEI, Dec. 13, 2021 /PRNewswire/ -- Taiwanese company Acura NanoMedicine Inc ( https://www.acura-nanomed.com/ ), an award-winning health tech and biomedicine company, announces a groundbreaking nanotech-based solution to reduce instances of drug resistance and giv...

2021-12-14 00:00 2579

CARsgen Presents Updated Research Results on BCMA CAR T-cell Product (CT053) at 2021 ASH Annual Meeting

SHANGHAI, Dec. 13, 2021 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, today announces that at the 2021 American Society of Hematology ("ASH") Annual ...

2021-12-13 20:00 6552

IASO Biotherapeutics and Innovent Biologics Announced Updated Clinical Data of BCMA CAR-T Therapy in Oral Presentation at 2021 ASH Annual Meeting

SAN JOSE and SAN FRANCISCO and NANJING, China, Dec. 12, 2021 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-cla...

2021-12-13 12:14 2879

StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer

SHANGHAI and BOSTON, Dec. 12, 2021 /PRNewswire/ -- StemiRNA, a leader in research and development of mRNA therapeutics, welcomes Dr.Jack Hu as Chief Financial Officer. Dr. Hu brings nearly two decades of experience in healthcare investment research, financial management and corporate strategy. Dr...

2021-12-13 07:00 2491

Omolle to Debut Ultimate Interactive Workout Mat "MATIV" at CES 2022

LAS VEGAS, Dec. 10, 2021 /PRNewswire/ -- Omolle, an interactive fitness services developer and a JV member of Born2Global Centre, will be launching its ultimate interactive workout mat "MATIV" at the Consumer Electronics Show 2022 (CES 2022), scheduled to take place from January 5 to 8 next year....

2021-12-10 21:30 4882

Concord Medical Reports Financial Results for the First Half of 2021

BEIJING, Dec. 10, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone...

2021-12-10 18:39 4952

Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan

TAIPEI, Taiwan, Dec. 8, 2021 /PRNewswire/ -- Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum, whereby the two parties will jointly invest up toNT$3 billion (approx. US$108 millio...

2021-12-10 12:17 4306
1 ... 308309310311312313314 ... 322